corporate_fare

Biomx Ltd.

Address
Floor 5, 22 Einstein Str

Sponsor Overview

assignment
1
sponsored trial
science
3
molecules
location_city
27
research centres
public
8
countries
person_search
29
investigators

Specializations

Respiratory Disease

Cystic fibrosis is the main therapeutic area in the sponsor’s clinical research, with a focus on chronic lung complications and infection-related disease burden.

  • Pulmonary infection
  • Chronic airway disease
  • Respiratory microbiology

The clinical program centers on respiratory outcomes in people living with cystic fibrosis, particularly conditions affecting the lungs and persistent infection.

Antibacterial and Antimicrobial Therapy

The sponsor’s research activity includes therapies directed at Pseudomonas aeruginosa, reflecting interest in infection control within the cystic fibrosis setting.

  • Pseudomonas lung infection
  • Antimicrobial treatment
  • Bacterial burden reduction

Attention is placed on managing persistent Pseudomonas colonization and its impact on respiratory health.

Phage-Based Therapeutics

Biomx Ltd. is involved in clinical research on bacteriophage-based approaches for infection-associated lung disease, with emphasis on targeted anti-bacterial activity.

  • Phage therapy
  • Targeted bacterial eradication
  • Nebulized delivery

The research landscape includes inhaled treatment strategies designed for direct action in the airways.

Inhaled Pulmonary Drug Development

The sponsor’s trial activity reflects interest in nebulized therapies for localized treatment of lung infection in cystic fibrosis.

  • Inhalation therapy
  • Sputum bacterial load
  • Airway-targeted treatment

This area focuses on therapies delivered directly to the respiratory tract to address infection within the lower respiratory tract.

Sponsored Trials

Trial Name Country Status
Evaluation of Nebulized BX004 in Adult Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Pulmonary Infection: A Phase 2b Randomized, Double-Blind, Placebo-Controlled StudyCzechia CzechiaFrance FranceGermany GermanyIreland IrelandItaly ItalyPoland PolandSpain SpainThe Netherlands The NetherlandsNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
3
Exclusive Molecules
out of 3 total (100% not shared with other sponsors)

This sponsor works with 3 molecules, of which 3 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 27 sites collaborated multiple times

This sponsor has worked with 27 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Respiratory Tract Diseases1 trial
    277 other sponsors

Partnered Research Centres

27 centres
location_city
assignment103
A.O.U. Policlinico G. Martino Di Messina
Address
Via Consolare Valeria N 1, 98124 Messina
Learn morearrow_forward
location_city
assignment680
Amsterdam UMC
Address
De Boelelaan 1117, 1081 HV Amsterdam
Learn morearrow_forward
location_city
assignment133
Azienda Ospedaliera Universitaria Meyer IRCCS
Address
Viale Gaetano Pieraccini 24, 50139 Florence
Learn morearrow_forward
location_city
assignment1199
Centre Hospitalier Lyon Sud
Address
165 Chemin Du Grand Revoyet, 69310 Pierre Benite
Learn morearrow_forward
location_city
assignment760
Centre Hospitalier Universitaire De Montpellier
Address
80 Avenue Augustin Fliche, 34295 Montpellier
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Biomx Ltd..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.